Trademarkia Logo

Canada

C$
Trademark Search in Canada
DCV TRIO PLAY DESIGN

View On IC.GC.CA

DCV TRIO PLAY DESIGN
REGISTERED

on 3 Sept 2019

Last Applicant/ Owned by

BRISTOL-MYERS SQUIBB HOLDINGS IRELAND UNLIMITED COMPANY

Hinterbergstrasse 166312 Steinhausen

CH

Serial Number

1746796 filed on 21st Sept 2015

Registration Number

TMA1052165 registered on 3rd Sept 2019

Registration expiry Date

3rd Sept 2029

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

DCV TRIO PLAY DESIGN

Trademark usage description

pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer Read More

Vienna Information

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 21

One letterUne lettre

26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 3

Rhombs or squares standing on one of the corners thereofLosanges ou carrés sur pointe

26 . 4 . 9

Several quadrilaterals juxtaposed, joined or intersectingPlusieurs quadrilatères, juxtaposés, accolés ou se coupant

Classification Information

Class [005]
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejection, hepatitis; pharmaceutical preparations for human use relating to metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents

Classification kind code

10

Mark Details

Serial Number

1746796

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 42
on 23rd Nov 2016		Advertised
Submitted for opposition 26
on 3rd Nov 2016		Approved
Submitted for opposition 27
on 15th Sept 2016		Approval Notice Sent
Submitted for opposition 22
on 31st May 2016		Search Recorded
Submitted for opposition 20
on 31st May 2016		Examiner's First Report
Submitted for opposition 68
on 25th Feb 2016		Rep for Service Name Changed
Submitted for opposition 67
on 25th Feb 2016		Agent Name Changed
Submitted for opposition 31
on 23rd Sept 2015		Formalized
Submitted for opposition 30
on 21st Sept 2015		Filed
Submitted for opposition 1
on 21st Sept 2015		Created